[go: up one dir, main page]

AU1710600A - Enhanced radiation therapy - Google Patents

Enhanced radiation therapy

Info

Publication number
AU1710600A
AU1710600A AU17106/00A AU1710600A AU1710600A AU 1710600 A AU1710600 A AU 1710600A AU 17106/00 A AU17106/00 A AU 17106/00A AU 1710600 A AU1710600 A AU 1710600A AU 1710600 A AU1710600 A AU 1710600A
Authority
AU
Australia
Prior art keywords
radiation therapy
enhanced radiation
enhanced
therapy
radiation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU17106/00A
Inventor
Edward R. Bacon
Gregory L. Mcintire
Gerald L. Wolf
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GE Healthcare AS
General Hospital Corp
Original Assignee
Nycomed Imaging AS
General Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9909799.0A external-priority patent/GB9909799D0/en
Application filed by Nycomed Imaging AS, General Hospital Corp filed Critical Nycomed Imaging AS
Publication of AU1710600A publication Critical patent/AU1710600A/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0038Radiosensitizing, i.e. administration of pharmaceutical agents that enhance the effect of radiotherapy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/10X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A61N2005/1085X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy characterised by the type of particles applied to the patient
    • A61N2005/1091Kilovoltage or orthovoltage range photons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/10X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A61N2005/1092Details
    • A61N2005/1098Enhancing the effect of the particle by an injected agent or implanted device

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Radiation-Therapy Devices (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
AU17106/00A 1998-10-29 1999-10-29 Enhanced radiation therapy Abandoned AU1710600A (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US18316698A 1998-10-29 1998-10-29
US09183166 1998-10-29
US13141899P 1999-04-28 1999-04-28
GBGB9909799.0A GB9909799D0 (en) 1999-04-28 1999-04-28 Method
US60131418 1999-04-28
GB9909799 1999-04-28
PCT/US1999/025558 WO2000025819A1 (en) 1998-10-29 1999-10-29 Enhanced radiation therapy

Publications (1)

Publication Number Publication Date
AU1710600A true AU1710600A (en) 2000-05-22

Family

ID=27269711

Family Applications (2)

Application Number Title Priority Date Filing Date
AU17106/00A Abandoned AU1710600A (en) 1998-10-29 1999-10-29 Enhanced radiation therapy
AU16017/00A Abandoned AU1601700A (en) 1998-10-29 1999-10-29 Radiodense compositions

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU16017/00A Abandoned AU1601700A (en) 1998-10-29 1999-10-29 Radiodense compositions

Country Status (5)

Country Link
EP (2) EP1124580A1 (en)
JP (2) JP2003520192A (en)
AU (2) AU1710600A (en)
CA (2) CA2347915A1 (en)
WO (2) WO2000025829A2 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7390668B2 (en) 1996-10-30 2008-06-24 Provectus Pharmatech, Inc. Intracorporeal medicaments for photodynamic treatment of disease
US6493570B1 (en) 1998-11-02 2002-12-10 Photogen, Inc. Method for improved imaging and photodynamic therapy
US6331286B1 (en) 1998-12-21 2001-12-18 Photogen, Inc. Methods for high energy phototherapeutics
US8974363B2 (en) 1997-12-11 2015-03-10 Provectus Pharmatech, Inc. Topical medicaments and methods for photodynamic treatment of disease
JP2003520192A (en) * 1998-10-29 2003-07-02 ザ ゼネラル ホスピタル コーポレーション Enhanced radiation therapy
US6986740B2 (en) 1998-11-02 2006-01-17 Xantech Pharmaceuticals, Inc. Ultrasound contrast using halogenated xanthenes
US8470296B2 (en) 1998-12-21 2013-06-25 Provectus Pharmatech, Inc. Intracorporeal medicaments for high energy phototherapeutic treatment of disease
US7384623B1 (en) 1998-12-21 2008-06-10 Provectus Pharmatech, Inc. High energy phototherapeutic agents
DE102008034020A1 (en) 2008-07-16 2010-01-21 Bayer Schering Pharma Aktiengesellschaft Contrast agent enhanced radiotherapy with high performance tubes
DE102010052613A1 (en) * 2010-11-29 2012-05-31 Stefan Brühl Heavy atoms containing substance, useful in a medical procedure, which is radiation therapy, preferably X-rays, for the treatment of tumors and to increase the biological effect of radiation, preferably X-rays
WO2015134845A1 (en) * 2014-03-07 2015-09-11 Stc.Unm Quantitatively describing biophysical markers

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5008907A (en) * 1989-05-31 1991-04-16 The Regents Of The University Of California Therapy x-ray scanner
US5660814A (en) * 1993-06-02 1997-08-26 Dibra S.P.A. Iodinated paramagnetic chelates, and their use as contrast agents
US5665330A (en) * 1995-02-08 1997-09-09 Nano Systems Llc Dual purposed diagnostic/therapeutic agent having a tri-iodinated benzoyl group linked to a coumarin
DE19627309C2 (en) * 1996-06-27 1999-07-29 Schering Ag Aqueous injectable formulations usable as contrast agents
EP0977593A1 (en) * 1997-04-24 2000-02-09 Nycomed Imaging A/S Embolus therapy using insoluble microparticles or vesicles containing contrast agents
JP2003520192A (en) * 1998-10-29 2003-07-02 ザ ゼネラル ホスピタル コーポレーション Enhanced radiation therapy
AR022404A1 (en) * 1999-01-25 2002-09-04 Photogen Inc METHOD AND AGENTS FOR IMPROVED RADIATION THERAPY

Also Published As

Publication number Publication date
WO2000025829A2 (en) 2000-05-11
CA2348536A1 (en) 2000-05-11
EP1126884A2 (en) 2001-08-29
EP1124580A1 (en) 2001-08-22
AU1601700A (en) 2000-05-22
JP2003520192A (en) 2003-07-02
WO2000025819A1 (en) 2000-05-11
WO2000025819A9 (en) 2000-09-21
JP2002528521A (en) 2002-09-03
WO2000025829A3 (en) 2000-11-30
CA2347915A1 (en) 2000-05-11

Similar Documents

Publication Publication Date Title
EG24678A (en) Combination therapy
AU5308700A (en) Radiation shield
AU2001263349A1 (en) Radiation therapy device having controllable radiation emission
AU2491900A (en) Radiation dosimetry system
AU5558499A (en) Radioactive therapeutic seeds
IL127306A0 (en) Combination therapy
HUP0104857A3 (en) New cancer treatments
AU4334499A (en) Radiation source
AU1772399A (en) Well treatment
AU1671600A (en) Electromagnetic radiation therapy
GB2339379B (en) Radiation therapy device
GB9700939D0 (en) Therapy
GB9816556D0 (en) Therapy
AU1710600A (en) Enhanced radiation therapy
AU4557300A (en) Radiation source
AU5946999A (en) Tumour therapy and imaging
GB9703633D0 (en) Cancer therapy
AU2453399A (en) Bone cancer therapy
AU1669600A (en) New cancer treatments
AU1579700A (en) Cytokine combination therapy
AU5524399A (en) Inorgasmia treatment
GB9806039D0 (en) Therapy
AUPP689198A0 (en) Therapeutic combination
AU2003200183A1 (en) Cholestrol-lowering Therapy
GB9701876D0 (en) Cancer therapy

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase